SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 195 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $116,000 | +728.6% | 28,019 | +1081.7% | 0.00% | – |
| Q1 2022 | $14,000 | -69.6% | 2,371 | -60.9% | 0.00% | -100.0% |
| Q4 2021 | $46,000 | -67.1% | 6,070 | -48.2% | 0.00% | -60.0% |
| Q2 2021 | $140,000 | +3400.0% | 11,715 | +3844.4% | 0.01% | – |
| Q1 2021 | $4,000 | -91.5% | 297 | -90.1% | 0.00% | -100.0% |
| Q4 2020 | $47,000 | +4600.0% | 2,989 | +1803.8% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 157 | +101.3% | 0.00% | – |
| Q4 2018 | $1,000 | -91.7% | 78 | -87.5% | 0.00% | -100.0% |
| Q1 2018 | $12,000 | +1100.0% | 622 | +776.1% | 0.01% | +500.0% |
| Q3 2017 | $1,000 | -87.5% | 71 | -92.5% | 0.00% | -87.5% |
| Q2 2017 | $8,000 | – | 942 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |